Loading...
Republic Healthcare Limited
8357.HK•HKSE
Healthcare
Medical - Care Facilities
HK$0.15
HK$-0.02(-10.59%)
Republic Healthcare Limited (8357.HK) Financial Performance & Income Statement Overview
Review Republic Healthcare Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-7.74%
↓ 7.74%
Operating Income Growth
0.00%
Net Income Growth
79.17%
↑ 79.17%
Operating Cash Flow Growth
-86.10%
↓ 86.10%
Operating Margin
11.13%
↑ 11.13%
Gross Margin
24.45%
↑ 24.45%
Net Profit Margin
-1.93%
↓ 1.93%
ROE
-1.42%
↓ 1.42%
ROIC
7.88%
↑ 7.88%
Republic Healthcare Limited (8357.HK) Income Statement & Financial Overview
Review Republic Healthcare Limited's (8357.HK) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $2.31M | $2.31M | $2.30M | $2.30M |
| Cost of Revenue | $1.80M | $1.80M | $1.69M | $1.69M |
| Gross Profit | $518195.00 | $518195.00 | $609904.00 | $609904.00 |
| Gross Profit Ratio | $0.22 | $0.22 | $0.27 | $0.27 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $278279.00 | $278279.00 | $0.00 | $0.00 |
| Operating Expenses | $278279.00 | $278279.00 | $0.00 | $672160.00 |
| Total Costs & Expenses | $2.07M | $2.07M | $1.69M | $2.36M |
| Interest Income | $0.00 | $0.00 | $11175.00 | $11175.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $46568.00 | $46568.00 | $52188.00 | $52188.00 |
| EBITDA | -$84325.00 | -$84325.00 | -$10068.00 | -$10068.00 |
| EBITDA Ratio | -$0.04 | -$0.04 | -$0.004 | -$0.004 |
| Operating Income | $239916.00 | $239916.00 | $609904.00 | -$62256.00 |
| Operating Income Ratio | $0.10 | $0.10 | $0.27 | -$0.03 |
| Other Income/Expenses (Net) | -$258260.00 | -$258260.00 | -$683335.00 | -$683335.00 |
| Income Before Tax | -$18344.00 | -$18344.00 | -$73431.00 | -$73431.00 |
| Income Before Tax Ratio | -$0.008 | -$0.008 | -$0.03 | -$0.03 |
| Income Tax Expense | $3840.00 | $3840.00 | $1144.00 | $1144.00 |
| Net Income | -$14504.00 | -$14504.00 | -$74575.00 | -$74575.00 |
| Net Income Ratio | -$0.006 | -$0.006 | -$0.03 | -$0.03 |
| EPS | -$0.00 | -$0.00 | -$0.00 | -$0.00 |
| Diluted EPS | -$0.00 | -$0.00 | -$0.00 | -$0.00 |
| Weighted Avg Shares Outstanding | $630.61M | $630.61M | $626.68M | $626.68M |
| Weighted Avg Shares Outstanding (Diluted) | $624.00M | $624.00M | $624.00M | $624.00M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan